Gueron G - Search Results

1

Heme Oxygenase 1 Impairs Glucocorticoid Receptor Activity in Prostate Cancer.

Leonardi DB, Anselmino N, Brandani JN, Jaworski FM, Páez AV, Mazaira G, Meiss RP, Nuñez M, Nemirovsky SI, Giudice J, Galigniana M, Pecci A, Gueron G, Vazquez E, Cotignola J. Leonardi DB, et al. Among authors: gueron g. Int J Mol Sci. 2019 Feb 26;20(5):1006. doi: 10.3390/ijms20051006. Int J Mol Sci. 2019. PMID: 30813528 Free PMC article.

2

Critical role of endogenous heme oxygenase 1 as a tuner of the invasive potential of prostate cancer cells.

Gueron G, De Siervi A, Ferrando M, Salierno M, De Luca P, Elguero B, Meiss R, Navone N, Vazquez ES. Gueron G, et al. Mol Cancer Res. 2009 Nov;7(11):1745-55. doi: 10.1158/1541-7786.MCR-08-0325. Epub 2009 Nov 10. Mol Cancer Res. 2009. PMID: 19903769

3

Key questions in metastasis: new insights in molecular pathways and therapeutic implications.

Gueron G, De Siervi A, Vazquez E. Gueron G, et al. Curr Pharm Biotechnol. 2011 Nov;12(11):1867-80. doi: 10.2174/138920111798376996. Curr Pharm Biotechnol. 2011. PMID: 21470130 Review.

4

BRCA1 loss induces GADD153-mediated doxorubicin resistance in prostate cancer.

De Luca P, Vazquez ES, Moiola CP, Zalazar F, Cotignola J, Gueron G, Gardner K, De Siervi A. De Luca P, et al. Among authors: gueron g. Mol Cancer Res. 2011 Aug;9(8):1078-90. doi: 10.1158/1541-7786.MCR-11-0155. Epub 2011 Jun 23. Mol Cancer Res. 2011. PMID: 21700680 Free PMC article.

5

Heme oxygenase 1 (HO-1) challenges the angiogenic switch in prostate cancer.

Ferrando M, Gueron G, Elguero B, Giudice J, Salles A, Leskow FC, Jares-Erijman EA, Colombo L, Meiss R, Navone N, De Siervi A, Vazquez E. Ferrando M, et al. Among authors: gueron g. Angiogenesis. 2011 Dec;14(4):467-79. doi: 10.1007/s10456-011-9230-4. Epub 2011 Aug 11. Angiogenesis. 2011. PMID: 21833623

6

Advanced prostate cancer: reinforcing the strings between inflammation and the metastatic behavior.

Gueron G, De Siervi A, Vazquez E. Gueron G, et al. Prostate Cancer Prostatic Dis. 2012 Sep;15(3):213-21. doi: 10.1038/pcan.2011.64. Epub 2011 Dec 20. Prostate Cancer Prostatic Dis. 2012. PMID: 22183772 Review.

7

Unveiling the association of STAT3 and HO-1 in prostate cancer: role beyond heme degradation.

Elguero B, Gueron G, Giudice J, Toscani MA, De Luca P, Zalazar F, Coluccio-Leskow F, Meiss R, Navone N, De Siervi A, Vazquez E. Elguero B, et al. Among authors: gueron g. Neoplasia. 2012 Nov;14(11):1043-56. doi: 10.1593/neo.121358. Neoplasia. 2012. PMID: 23226098 Free PMC article.

8

Heme-oxygenase-1 implications in cell morphology and the adhesive behavior of prostate cancer cells.

Gueron G, Giudice J, Valacco P, Paez A, Elguero B, Toscani M, Jaworski F, Leskow FC, Cotignola J, Marti M, Binaghi M, Navone N, Vazquez E. Gueron G, et al. Oncotarget. 2014 Jun 30;5(12):4087-102. doi: 10.18632/oncotarget.1826. Oncotarget. 2014. PMID: 24961479 Free PMC article.

9

Differential effect of heterocyclic D-ribofuranoside derivatives on human prostate cancer cell viability and cell cycle progression.

Gueron G, Avanzo RE, Schuster F, Carabelos MN, Vazquez E, Fascio ML, D'Accorso NB. Gueron G, et al. Biomed Pharmacother. 2014 Sep;68(7):847-54. doi: 10.1016/j.biopha.2014.08.010. Epub 2014 Aug 19. Biomed Pharmacother. 2014. PMID: 25217395

10

Association of HO-1 and BRCA1 Is Critical for the Maintenance of Cellular Homeostasis in Prostate Cancer.

Labanca E, De Luca P, Gueron G, Paez A, Moiola CP, Massillo C, Porretti J, Giudice J, Zalazar F, Navone N, Vazquez E, De Siervi A. Labanca E, et al. Among authors: gueron g. Mol Cancer Res. 2015 Nov;13(11):1455-64. doi: 10.1158/1541-7786.MCR-15-0150-T. Epub 2015 Jul 30. Mol Cancer Res. 2015. PMID: 26227317

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39 results

Search Page